Product Information

NITROFURANTOIN MONO-MCR 100 MG is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2719 per EA under NDC 59746076206. Its NADAC has been published 92 times since Feb 12, 2025.

FDA first approved this application on Feb 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NITROFURANTOIN MONO-MCR 100 MG

Nitrofurantoin (monohydrate/macrocrystals)
$0.2719per EA

Strength

25; 75 mg/1; mg/1

NDC

59746076206

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211013

FDA Approved

2/18/2022

TE Code

AB

On Market Since

2/22/2022

Pharmacological Classes

Price Statistics

The NADAC for NITROFURANTOIN MONO-MCR 100 MG has been published 92 times since Feb 12, 2025, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2719 per EA
All-time high$0.3519 (Jan 14, 2026)
All-time low$0.2719 (Oct 21, 2026)
52-week high$0.3519
52-week low$0.2719
Median price$0.3289
Average price$0.3252
Largest weekly change+8.3% (Feb 19, 2025)
Weeks tracked92
Tracking sinceFeb 12, 2025

Price History

1W

0.0%

1M

-8.1%

3M

-8.7%

6M

-15.7%

1Y

-20.0%

3Y

N/A

5Y

N/A

All

-4.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NITROFURANTOIN MONO-MCR 100 MG?

The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MONO-MCR 100 MG, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2719 per EA (NDC 59746076206), effective Nov 11, 2026.

How has the price of NITROFURANTOIN MONO-MCR 100 MG changed over time?

Over the history we have for it, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has declined 4.4%. It has been tracked across 92 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MONO-MCR 100 MG?

Since Feb 12, 2025, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has ranged from a low of $0.2719 (Oct 21, 2026) to a high of $0.3519 (Jan 14, 2026), with a median of $0.3289 per EA.

Are there cheaper alternatives to NITROFURANTOIN MONO-MCR 100 MG?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NITROFURANTOIN MONO-MCR 100 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures NITROFURANTOIN MONO-MCR 100 MG?

NITROFURANTOIN MONO-MCR 100 MG (NDC 59746076206) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.